drugset / Trial / NCT02669667
Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects
RandomizedParallel-groupDouble-blindBasic science
Summary
This is a phase 1a randomized, blinded, placebo-controlled, single-ascending dose study to assess the safety and tolerability of MEDI9314 in healthy adult subjects
Timeline
- Start
- 2016-02-18
- Primary completion
- 2016-11-17
- Completion
- 2017-06-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MEDI9314 | Unknown | — | — |
Indications
No indication recorded.